SBFM did a 1-for-20 reverse split on Oct 26, 2026. Fund positions use its last close before the split, $0.1500 on Oct 23, 2026, until the new shares are matched.

SBFM

Sunshine Biopharma Inc.

TickerSBFM
13D/G
SecurityCommon Stock · US
CUSIP867781809

SBFM institutional ownership changes in Q2 2026: 6 institutions opened or added positions, 0 trimmed or exited. SBFM (Sunshine Biopharma Inc.) is held by 6 institutional investors as of Q2 2026. Top institutional shareholders: Jane Street Group, LLC ($31,445), Morgan Stanley ($808), National Bank of Canada ($10). Net institutional sentiment: Bullish.

6
Holders
$32,271
Total Value
100% (6)
Consensus
6 buying0 selling
Fund holdings as of
SBFM

Smart Money Verdict

View all
Loading verdict
Held by 6 funds

Who's Trading

Source dates: Price Nov 3, 2026 · Insiders Aug 11, 2026 · Activists Oct 14, 2026 · Congress none

ActivistBFBJI Financial Group6.0%
ActivistCICVI Investments, Inc.9.9%
ActivistALAlta Partners LLC4.9%
Checking access…

Top Holders

Checking access…
Action
New
14,974$31,4450.0%-92.86%
30
New
385$8080.0%-92.86%
17
New
5$100.0%-92.86%
17
New
2$40.0%-92.86%
17
New
1$20.0%0.00%
17
New
1$20.0%-63.19%
17
Exited
0(-100.0%)$13,9700.0%-79.81%
0
Exited
0(-100.0%)$22,3150.0%-82.25%
0
Exited
0(-100.0%)$1,1470.0%-83.97%
0
Exited
0(-100.0%)$48,0980.0%-85.51%
0
Loading insider trades…
Loading Congress trades…
Loading activist filings…
SBFMSBFMSunshine Biopharma Inc.

Questions investors ask about SBFM

Who owns SBFM?

6 institutional investors held SBFM on June 30, 2026, led by Jane Street Group, LLC ($31,445), Morgan Stanley ($808) and National Bank of Canada ($10).

How many hedge funds hold SBFM?

6 institutional investors reported SBFM in their 13F filings for the quarter ended June 30, 2026, $32,271 in all.

Are institutions buying or selling SBFM?

Buying, on balance. In Q2 2026, 6 institutions opened or added to positions in SBFM and 0 institutions trimmed or exited.

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used